LifeScience Biologics

Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics

 Microba Life Sciences (ASX:MAP), a precision microbiome science company, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal ...

 April 05, 2022 | News

JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in Mantle Cell Lymphoma in China

Carteyva® is an anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product independently developed by JW Therapeutics. T...

 April 04, 2022 | News

BioVaxys Expands Cancer Vaccine Platform

BioVaxys Technology Corp. (CSE: BIOV), (FRA: 5LB), (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today the expansion of its cancer vaccine platf...

 March 31, 2022 | News

Telix Advances Development of Glioblastoma Therapy Program

TLX101 (4-L-[131I] iodo-phenylalanine, or 131I-IPA) is one of the Company's lead therapeutic clinical programs and has been granted orphan drug design...

 March 23, 2022 | News

Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries

Biolexis will launch AKS-452 as “AmbiVax-CTM” for global markets where the cold chain elimination would contribute to improving immunization ...

 March 21, 2022 | News

WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics

Sustainalytics' ESG Risk Ratings evaluate over 14,000 companies across 42 industries worldwide, measuring each company's exposure to industry-specific mate...

 March 15, 2022 | News

China NMPA Approves Tislelizumab for Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors

-BeiGene, Ltd. , a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and...

 March 14, 2022 | News

Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals

These deuterated compounds represent next-generation therapeutics with applications across several different psychiatric and neurological conditions. Terra...

 March 13, 2022 | News

Molecular Health collaborates to explore the molecular causation of adverse drug reactions

Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ² published a triad of articles that d...

 March 11, 2022 | News

Novavax Announces Launch of Global Vaccine Education Programs

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

 March 11, 2022 | News

Arctoris and Evariste Technologies form a Joint Venture to Identify Novel Small Molecule cMET Inhibitors for Non-Small Cell Lung Cancer

Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, today announced they have formed a joint venture to id...

 March 08, 2022 | News

Paras Biopharmaceuticals to expand global outreach of its ‘Biosimilar Development & Partnership’

Bioseet, based in Munich, Germany, is an enterprise encompassing a virtual marketplace and teamspace for Biosimilar and other generic assets to facilitate ...

 March 03, 2022 | News

Cambrex Expands Biopharmaceutical Services Business

 The expansion includes 11 additional cGMP laboratories at Cambrex's Durham, NC facility and broadens its service offering for large molecul...

 March 01, 2022 | News

Avivagen Announces Approval in Vietnam

“We are very excited to secure approval for our product in Vietnam, a critical feed market in Southeast Asia with strong growth potential over the co...

 February 24, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close